Cargando…
Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors
Influenza polymerase uses short capped primers snatched from nascent Pol II transcripts to initiate transcription of viral mRNAs. Here we describe crystal structures of influenza A and B polymerase bound to a capped primer in a configuration consistent with transcription initiation (’priming state’)...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778463/ https://www.ncbi.nlm.nih.gov/pubmed/29202182 http://dx.doi.org/10.1093/nar/gkx1210 |
_version_ | 1783294356325662720 |
---|---|
author | Pflug, Alexander Gaudon, Stephanie Resa-Infante, Patricia Lethier, Mathilde Reich, Stefan Schulze, Wiebke M Cusack, Stephen |
author_facet | Pflug, Alexander Gaudon, Stephanie Resa-Infante, Patricia Lethier, Mathilde Reich, Stefan Schulze, Wiebke M Cusack, Stephen |
author_sort | Pflug, Alexander |
collection | PubMed |
description | Influenza polymerase uses short capped primers snatched from nascent Pol II transcripts to initiate transcription of viral mRNAs. Here we describe crystal structures of influenza A and B polymerase bound to a capped primer in a configuration consistent with transcription initiation (’priming state’) and show by functional assays that conserved residues from both the PB2 midlink and cap-binding domains are important for positioning the capped RNA. In particular, mutation of PB2 Arg264, which interacts with the triphosphate linkage in the cap, significantly and specifically decreases cap-dependent transcription. We also compare the configuration of the midlink and cap-binding domains in the priming state with their very different relative arrangement (called the ‘apo’ state) in structures where the potent cap-binding inhibitor VX-787, or a close analogue, is bound. In the ‘apo’ state the inhibitor makes additional interactions to the midlink domain that increases its affinity beyond that to the cap-binding domain alone. The comparison suggests that the mechanism of resistance of certain mutations that allow virus to escape from VX-787, notably PB2 N510T, can only be rationalized if VX-787 has a dual mode of action, direct inhibition of capped RNA binding as well as stabilization of the transcriptionally inactive ‘apo’ state. |
format | Online Article Text |
id | pubmed-5778463 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57784632018-01-30 Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors Pflug, Alexander Gaudon, Stephanie Resa-Infante, Patricia Lethier, Mathilde Reich, Stefan Schulze, Wiebke M Cusack, Stephen Nucleic Acids Res Structural Biology Influenza polymerase uses short capped primers snatched from nascent Pol II transcripts to initiate transcription of viral mRNAs. Here we describe crystal structures of influenza A and B polymerase bound to a capped primer in a configuration consistent with transcription initiation (’priming state’) and show by functional assays that conserved residues from both the PB2 midlink and cap-binding domains are important for positioning the capped RNA. In particular, mutation of PB2 Arg264, which interacts with the triphosphate linkage in the cap, significantly and specifically decreases cap-dependent transcription. We also compare the configuration of the midlink and cap-binding domains in the priming state with their very different relative arrangement (called the ‘apo’ state) in structures where the potent cap-binding inhibitor VX-787, or a close analogue, is bound. In the ‘apo’ state the inhibitor makes additional interactions to the midlink domain that increases its affinity beyond that to the cap-binding domain alone. The comparison suggests that the mechanism of resistance of certain mutations that allow virus to escape from VX-787, notably PB2 N510T, can only be rationalized if VX-787 has a dual mode of action, direct inhibition of capped RNA binding as well as stabilization of the transcriptionally inactive ‘apo’ state. Oxford University Press 2018-01-25 2017-11-30 /pmc/articles/PMC5778463/ /pubmed/29202182 http://dx.doi.org/10.1093/nar/gkx1210 Text en © The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Structural Biology Pflug, Alexander Gaudon, Stephanie Resa-Infante, Patricia Lethier, Mathilde Reich, Stefan Schulze, Wiebke M Cusack, Stephen Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors |
title | Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors |
title_full | Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors |
title_fullStr | Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors |
title_full_unstemmed | Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors |
title_short | Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors |
title_sort | capped rna primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors |
topic | Structural Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778463/ https://www.ncbi.nlm.nih.gov/pubmed/29202182 http://dx.doi.org/10.1093/nar/gkx1210 |
work_keys_str_mv | AT pflugalexander cappedrnaprimerbindingtoinfluenzapolymeraseandimplicationsforthemechanismofcapbindinginhibitors AT gaudonstephanie cappedrnaprimerbindingtoinfluenzapolymeraseandimplicationsforthemechanismofcapbindinginhibitors AT resainfantepatricia cappedrnaprimerbindingtoinfluenzapolymeraseandimplicationsforthemechanismofcapbindinginhibitors AT lethiermathilde cappedrnaprimerbindingtoinfluenzapolymeraseandimplicationsforthemechanismofcapbindinginhibitors AT reichstefan cappedrnaprimerbindingtoinfluenzapolymeraseandimplicationsforthemechanismofcapbindinginhibitors AT schulzewiebkem cappedrnaprimerbindingtoinfluenzapolymeraseandimplicationsforthemechanismofcapbindinginhibitors AT cusackstephen cappedrnaprimerbindingtoinfluenzapolymeraseandimplicationsforthemechanismofcapbindinginhibitors |